MedTrace Logo

Effect of InFat™ Product on Stool Biochemistry and Stool Characteristics in Formula-fed Term Infants in China

NCT01373541 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 171

Last updated 2014-02-13

No results posted yet for this study

Summary

The purpose of this study is to determine the effect of infant formula with high percentage of palmitic acid at the sn-2 position (InFat™) on improving fat absorption and general gastrointestinal tolerance in Chinese formula-fed term infants.

Conditions

  • Health Behavior
  • Personal Satisfaction

Interventions

OTHER

InFat™ based infant formula

high sn-2 palmitic acid oil based infant formula

OTHER

Standard vegetable oil based infant formula

standard vegetable oil based infant formula

Sponsors & Collaborators

  • Biostime, Inc. (Guangzhou)

    collaborator INDUSTRY

  • Enzymotec

    lead INDUSTRY

Principal Investigators

  • Xu Chundix, Prof. · Ruijin Hospital

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Day
Max Age
14 Days
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-05-31
Primary Completion
2012-12-31
Completion
2013-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01373541 on ClinicalTrials.gov